Jin Medical International Ltd, a wheelchair and living aids products manufacturer, has filed Form F-1 Registration Statement on September 24, 2021 with the U.S. Securities and Exchange Commission to raise up to $33 million IPO. Pricing terms are yet to announce.
The company design and manufacture wheelchairs and living aids products for people with disabilities, the elderly, and people recovering from injury. Most of their products are sold to dealers in Japan and China.
The Changzhou, China-based company was founded in 2006 and booked $18 million in sales for the 12 months ended March 31, 2021. It plans to list on the Nasdaq Capital Market but has not selected a symbol yet (RC ticker: JNMI.RC). Prime Number Capital is the underwriter of the IPO.
The company engages Hunter Taubman Fischer & Li LLC as US Securities Counsel, and Friedman LLP as Independent Auditor.
#ipo #Nasdaq #JinMedicalInternational #wheelchair
Hexcellence Consulting has experienced IPO consulting team focus on listing in US Stock Market,
namely NYSE, Nasdaq and OTC Markets.
Should you interested to list your company in US Stock Market,
please contact us at [email protected]
